TMC Life Sciences Berhad

Total Valuation

TMC Life Sciences Berhad carries a market capitalization of 783.85M, placing it among publicly traded companies globally. Its enterprise value stands at 874.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

TMC Life Sciences Berhad currently has 1.74B shares outstanding.

Valuation Ratios

TMC Life Sciences Berhad trades at a trailing price-to-earnings ratio of 55.17. The price-to-sales ratio is 2.16, and the price-to-book ratio stands at 0.97.

Enterprise Valuation

On an enterprise value basis, TMC Life Sciences Berhad trades at an EV/EBITDA multiple of 39.24 and an EV/FCF ratio of 9.97. The EV/Sales ratio of 2.26 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 39.24 provides insight into valuation relative to core operating earnings.

Financial Position

TMC Life Sciences Berhad maintains a current ratio of 1.82, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.10, indicating elevated leverage, while an interest coverage ratio of 2.77 demonstrates limited ability to service its debt obligations.

Financial Efficiency

TMC Life Sciences Berhad posts a return on equity of 1.77 and a return on invested capital of 1.51.

Taxes

Over the trailing twelve months, TMC Life Sciences Berhad has paid 6.55M in income taxes, reflecting an effective tax rate of 30.19.

Stock Price Statistics

TMC Life Sciences Berhad's stock has gained approximately 4.65116% over the past 52 weeks. The 50-day moving average sits at 0.47, while the 200-day moving average is 0.47.

Income Statement

Over the trailing twelve months, TMC Life Sciences Berhad generated 386.95M in revenue and converted that into 15.15M in net income, yielding earnings per share of 0.01. EBITDA reached 22.28M, while operating income came in at 22.28M.

Balance Sheet

TMC Life Sciences Berhad holds 118.12M in cash and equivalents against 156.15M in total debt, resulting in a net debt position of 34.75M. Total book value stands at 862.53M, with working capital of 88.25M providing operational flexibility.

Cash Flow

TMC Life Sciences Berhad produced 60.39M in operating cash flow over the past twelve months. After subtracting -21.67M in capital expenditures, free cash flow totaled 38.72M - equivalent to 0.02 per share.

Margins

TMC Life Sciences Berhad operates with a gross margin of 63.47, reflecting its pricing power and cost economics. The operating margin of 5.76 and net profit margin of 3.92 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

TMC Life Sciences Berhad's most recent stock split took place on November 21, 2011 with a 125:136 split ratio.

Scores

TMC Life Sciences Berhad posts an Altman Z-Score of 3.01, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.